Sunrest Lifescience Fair Value
Fair Value Analysis Export
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
SUNREST Fair Value Analysis — Data Sources & Coverage
Sunrest Lifescience financial data sources, valuation methods applied and sector benchmarks used. Browse SUNREST complete financial statements for revenue, profit, balance sheet and cash flow data.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
SUNREST vs Healthcare Sector Peers — P/E, P/B & Market Cap
Sunrest Lifescience P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Aurobindo Pharma | AUROPHARMA | 25.88 | 2.53 | ₹96,652 |
| Emcure Pharmaceuticals | EMCURE | 36.8 | 7.52 | ₹37,799 |
| Sat Kartar Life | SATKARTAR | 13.37 | 3.34 | ₹226 |
| Syngene International | SYNGENE | 69.95 | 3.2 | ₹15,307 |
| Divis Laboratories | DIVISLAB | 85.36 | 14.9 | ₹247,470 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.